In this article

The name on a weight-loss website can describe the company, the drug ingredient, or a finished medication. Those names are easy to confuse when a search result puts them side by side. Understanding the difference helps you ask for the right prescription and compare the actual treatment.

This article answers the medication-name question directly, then explains formulation, prescribing, pharmacy fulfillment, and switching. Our sources are product labeling, FDA guidance, and dated TrimRx disclosures. They describe documents and advertised services; they do not establish a head-to-head treatment result.

THE SHORT ANSWER

No. TrimRx is a telehealth platform; Wegovy is an FDA-approved semaglutide medication brand. A compounded prescription obtained through TrimRx is not automatically the same product, and it should not be described as an FDA-approved generic version.

What to know first

  • No. TrimRx is a telehealth platform; Wegovy is an FDA-approved semaglutide medication brand. A compounded prescription obtained through TrimRx is not automatically the same product, and it should not be described as an FDA-approved generic version.
  • Confirm the details against the prescription or plan offered to you.
  • Use the dated sources below and retain the response from the provider.

Is TrimRx the same as Wegovy?

No. TrimRx is a telehealth platform; Wegovy is an FDA-approved semaglutide medication brand. A compounded prescription obtained through TrimRx is not automatically the same product, and it should not be described as an FDA-approved generic version.

Wegovy is Novo Nordisk’s FDA-approved semaglutide brand. The current prescribing information includes injection and tablet formulations, with indications and patient groups that depend on the formulation. A compounded semaglutide vial or pill is not Wegovy simply because the active-ingredient name is similar.

    What does TrimRx actually arrange?

    The TrimRx disclosure captured on September 21 describes a primary compounded-medication program. It also says a clinician may write a branded prescription, but TrimRx does not sell, dispense, or ship the branded product: the patient fills it at a chosen pharmacy and pays those costs separately.

    Our September 23 attempts to reload the main disclosure were blocked. We retain the dated text and identify that limitation. Ask the clinician to put the exact product, ingredient, route, and dispensing pharmacy on the proposed prescription; a general blog discussing a drug does not establish that it is included in your quote.

      Does a shared ingredient make the treatments interchangeable?

      No. Even where a prescription contains semaglutide, the finished preparation, delivery device, concentration, and instructions can differ. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Evidence for an approved brand does not establish equivalence for every compound.

      Read the actual pharmacy label before comparing prices. A monthly program fee may cover consultation and a compounded preparation, while a branded prescription may involve a separate pharmacy bill. A lower advertised price does not establish that the same product is being offered.

        What if you want to switch?

        Bring the current prescription and dispensing label to the new clinician. Ask whether the proposed treatment is Wegovy, a different approved brand, or a compound. Have the clinician explain how the change affects follow-up and the next prescription.

        Do not copy syringe units, reuse another product’s instructions, or combine overlapping treatments on your own. The relevant question is whether the exact proposed prescription is appropriate for you, not whether two websites use the same ingredient in their advertising. See our TrimRx patient questions for eligibility, refills, and support.

          What should the prescription actually identify?

          A useful comparison begins with the prescription, not the logo on the checkout screen. Record the complete medication name, active ingredient, route, strength or concentration, and dispensing pharmacy. These details show whether the proposal concerns a manufacturer’s approved product or a pharmacy’s compounded preparation. A telehealth company can coordinate care without being the manufacturer or the pharmacy.

          A quoted monthly amount also needs a clear description. It may cover access to clinical care, a medication supply, or both. When a branded prescription is filled outside the program, the drug bill can be separate from the platform fee. Ask which charges remain if the requested product cannot be prescribed or filled.

            How should you compare a current prescription with a new offer?

            Use the label from the medicine you actually receive. An advertisement saying “tirzepatide” does not answer whether the preparation is Zepbound, Mounjaro, or a compound. Likewise, the word semaglutide does not identify one formulation or one approved indication. Brand-specific prescribing information applies to that product and should not be transferred to a different preparation.

            If you already take medication, share the label and treatment history with the receiving clinician before changing services. Ask who will manage follow-up and how any interruption will be handled. Do not translate a previous syringe marking into a new product’s instructions. The pharmacy should explain the exact label; the clinician should decide the treatment. For a buying decision, compare those responsibilities alongside price.

              Specify which Wegovy formulation you mean

              The current Wegovy label includes tablets as well as injections. That makes the route a necessary part of the question: requesting Wegovy alone may leave the formulation unclear. Ask the clinician which product is under consideration and which labeled information applies to it. Do not treat a compounded oral preparation as Wegovy tablets, or assume an injection’s instructions apply to a tablet. TrimRx’s historical description of branded prescribing also separates the prescription service from the outside pharmacy purchase. Confirm both the formulation and the financial arrangement in the offer you receive.

                Sources & research notes

                Checked September 23, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

                1. Personalized Weight Loss Programs That Work | TrimRxProvider-published information · Checked September 21, 2026
                2. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDARegulatory / public agency · Checked September 23, 2026
                3. Wegovy: current US prescribing informationPrescribing information · Checked September 23, 2026

                Read our methodology · Commercial disclosure · Request a correction